Glioblastoma Multiforme
Showing NaN - NaN of 35
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity
Recruiting
- Astrocytoma, Grade IV
- +3 more
- CYNK-001 systemic and Intra cavity administration
-
Duarte, California
- +5 more
Jan 20, 2023
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)
Recruiting
- Glioblastoma Multiforme
- Recurrent Glioblastoma
- TheraSphere GBM
-
San Francisco, California
- +4 more
Aug 15, 2022
Glioblastoma Multiforme, Brain Tumors Trial in United States (OncoGel (ReGel/Paclitaxel))
Terminated
- Glioblastoma Multiforme
- Brain Neoplasms
- OncoGel (ReGel/Paclitaxel)
-
Chicago, Illinois
- +4 more
Jun 2, 2022
Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)
Active, not recruiting
- Glioblastoma Multiforme
- +6 more
- Dendritic cell immunotherapy
-
Birmingham, Alabama
- +85 more
May 12, 2022
Glioblastoma Multiforme, Anaplastic Oligoastrocytoma Trial in United States (Ad-RTS-hIL-12, veledimex)
Completed
- Glioblastoma Multiforme
- Anaplastic Oligoastrocytoma
- Ad-RTS-hIL-12
- veledimex
-
Los Angeles, California
- +5 more
Sep 21, 2021
Glioblastoma Multiforme Trial in Worldwide (drug, other, radiation)
Terminated
- Glioblastoma Multiforme
- Steroid eye drops
- +6 more
-
Los Angeles, California
- +21 more
Mar 19, 2021
Glioblastoma Multiforme Trial in United States (Bevacizumab and Temozolomide)
Completed
- Glioblastoma Multiforme
- Bevacizumab and Temozolomide
-
Chicago, Illinois
- +4 more
Mar 5, 2021
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Chicago, Baltimore, Saint Paul (PAC-1 Compound)
Suspended
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- PAC-1 Compound
-
Chicago, Illinois
- +2 more
Sep 18, 2020
Glioblastoma Multiforme, Astrocytoma, Grade III, Anaplastic Ependymoma Trial in Chicago (biological, procedure, radiation)
Terminated
- Glioblastoma Multiforme
- +4 more
- Heat Shock Protein Peptide Complex-96 (HSPPC-96)
- +2 more
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago
Jul 24, 2020
Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)
Completed
- Glioblastoma Multiforme
- +3 more
- Indoximod
- +3 more
-
Castro Valley, California
- +16 more
May 26, 2020
Glioblastoma Multiforme Trial in United States (biological, drug, other)
Completed
- Glioblastoma Multiforme
- bevacizumab
- +2 more
-
Scottsdale, Arizona
- +304 more
Oct 4, 2019
Glioblastoma Multiforme Trial in United States (Cilengitide 500 mg, Cilengitide 2000 mg)
Completed
- Glioblastoma Multiforme
- Cilengitide 500 mg
- Cilengitide 2000 mg
-
Birmingham, Alabama
- +16 more
Jan 18, 2019
Glioblastoma Multiforme Trial in Austria, Canada, United States (ICT-107, Placebo)
Suspended
- Glioblastoma Multiforme
- ICT-107
- Placebo
-
Birmingham, Alabama
- +64 more
Aug 9, 2018
Adult Brain Glioblastoma, Glioblastoma Multiforme Trial in United States (SL-701; poly-ICLC (polyinosinic-polycytidylic acid
Completed
- Adult Brain Glioblastoma
- Glioblastoma Multiforme
- SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose)
- Bevacizumab
-
Birmingham, Alabama
- +15 more
Jan 24, 2018
Glioblastoma Multiforme Trial in Worldwide (NovoTTF-100A device, Temozolomide)
Completed
- Glioblastoma Multiforme
- NovoTTF-100A device
- Temozolomide
-
Birmingham, Alabama
- +88 more
Apr 7, 2017
Glioblastoma Multiforme Trial in United States (ICT-107, Placebo DC)
Completed
- Glioblastoma Multiforme
- ICT-107
- Placebo DC
-
South Birmingham, Alabama
- +24 more
Feb 10, 2017
Brain Tumor, Recurrent, Glioblastoma Multiforme Trial in Chicago (Photon Radiosurgery System (Intrabeam))
Completed
- Brain Tumor, Recurrent
- Glioblastoma Multiforme
- Photon Radiosurgery System (Intrabeam)
-
Chicago, IllinoisChildren's Memorial Hospital
Feb 27, 2015